WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis. - Wikidata - awgldk - TriplyDB

WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis.

WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis.

http://www.wikidata.org/entity/Q35683131

about

WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transition.Fluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors.Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer.Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl Wee1 kinase as a target for cancer therapy.Breast cancer proteome takes more than two to tango on TRAIL: beat them at their own game.Targeting TRAIL in the treatment of cancer: new developments.Simultaneously expressed miR-424 and miR-381 synergistically suppress the proliferation and survival of renal cancer cells---Cdc2 activity is up-regulated by targeting WEE1.Reconstructing cancer drug response networks using multitask learning.Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.Highlights on molecular targets for radiosensitization of breast cancer cells: Current research status and prospects WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy Inactivation of PRIM1 Function Sensitizes Cancer Cells to ATR and CHK1 Inhibitors

P2860

Q33570786-F301011A-3FC2-4382-AD60-F58D19BFB65B Q34014165-415FEA3A-1F82-4F84-9F2D-2D812859ADB1 Q34584599-C810C1B2-C7A3-4A61-B4A5-64C2165E35CA Q36338764-EFE789AF-4F21-43B0-BC92-2D2A02ED48E9 Q36580632-FB4FC6C6-D854-46FD-8165-926559B4DAC6 Q37396839-215C0EDA-FE83-4FAD-BE82-2067B075EA36 Q38035209-1EF7E117-091B-4EE0-B0A3-980FAD48AE0D Q38500801-B0CB479D-6075-48EA-8033-060E94FA252F Q39137856-C03D8239-CC8B-4303-A6A7-00300ED0465E Q42374512-6428BD20-25D1-4DCA-B7FA-1AB73D6CC00D Q52615755-0AA4C322-3818-462E-9567-68B24C376EF9 Q57111986-91362B51-0E51-40F9-880E-79E2FE6E5ED0 Q57138889-BC016040-81ED-453B-8EFC-4F7DC93CF2A4 Q58701948-7534831E-E35C-43CC-98E9-D4831C5124AA

P2860

WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis.

http://www.wikidata.org/entity/Q35683131

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis.

@ast

WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis.

@en

type

label

WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis.

@ast

WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis.

@en

prefLabel

WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis.

@ast

WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis.

@en

P1433

Q35683131-BEABB89E-14C3-41A8-A8E6-DBA44CCE913F

P1476

Q35683131-83BEDC00-58DC-4DD8-821A-4D3F3B5C740B

P2093

Q35683131-0232B259-95FC-419E-B585-059FAAF059D0

Q35683131-B5871955-9D1C-4C1A-B9F6-4D634974E99D

P2860

Q35683131-05992581-0F2F-4D5F-B8D8-E6893B50835D

Q35683131-0DEBF863-B7B1-4B55-99C0-F6E49B74E38E

Q35683131-0F10CBC8-C5E6-43AB-B2C9-DF2FD8D98439

Q35683131-12B895C2-0236-4591-A90F-67E04137CC16

Q35683131-14B1C6F0-32E4-45B3-9933-7D5CBAEB2CC7

Q35683131-160D8691-D884-44FC-80EA-61E767EA8501

Q35683131-1E0FAE93-9871-40A5-B8CC-A57528738A8C

Q35683131-25F8B674-E8FE-42C6-A40A-9CF49D7E3A33

Q35683131-2C024974-3165-457D-86A1-84954103D986

Q35683131-2EFF502D-0238-4C57-A805-B4F3771600D7

P304

Q35683131-EE36727A-3A40-4DF9-83CE-6BCAF3A91E12

P31

Q35683131-4A868849-5BD3-4FDD-8100-C395BEB6C6C9

P356

Q35683131-3F9BACF0-7053-468B-BDE4-74FC4857980F

P433

Q35683131-EB6A48D0-3D26-4D9B-98A1-A0A37D41AC5C

P478

Q35683131-ADD7D59D-AA46-4C1C-9740-70008EAB6CCD

P50

Q35683131-F6A29D42-E6C3-4960-9BC7-42B1308C2AA4

P577

Q35683131-E07F9DF5-F933-4881-A9A9-3DB1AD1B13D9

P698

Q35683131-D8660535-6FCA-449A-BEA7-BDBFB4B83AB2

P932

Q35683131-25F392FA-EDDC-4EF8-B455-CB507E57F5A3

P356

1541-7786.MCR-11-0500

P1433

Molecular Cancer Research

P1476

WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis

@en

P2093

Sireesha V Garimella

http://www.w3.org/2001/XMLSchema#string

Stanley Lipkowitz

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

Caspases: the executioners of apoptosis

Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

Molecular mechanisms of caspase regulation during apoptosis

Hallmarks of 'BRCAness' in sporadic cancers

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.

P304

75-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1541-7786.MCR-11-0500

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22112940

http://www.w3.org/2001/XMLSchema#string

P932

3262068

http://www.w3.org/2001/XMLSchema#string